U.S. to boost monkeypox vaccine supply with 1.8 million extra doses
Send a link to a friend
[August 19, 2022]
By Ahmed Aboulenein and Kanishka Singh
WASHINGTON (Reuters) -The United States
said on Thursday it will boost its supply of monkeypox vaccine by making
available an extra 1.8 million doses of Bavarian Nordic's Jynneos shot,
as the number of reported cases in the country rose above 13,500.
Rochelle Walensky, director of the Centers for Disease Control and
Prevention (CDC), gave the figure for reported cases as of Aug.17, which
represent more than a third of the global total of 39,000, at a White
House briefing.
"It's critical that we do all we can to keep this dangerous virus from
spreading," Secretary of Health and Human Services Xavier Becerra said
at the briefing.
The Department of Health and Human Services (HHS) is making 360,000
vaccine vials available to order from next week, said Assistant
Secretary for Preparedness and Response Dawn O'Connell, which is the
equivalent of 1.8 million doses.
The U.S. Food and Drug Administration (FDA) last week authorized
administering Bavarian Nordic's Jynneos shot intradermally, between the
layers of the skin, increasing by fivefold the doses that can be used
from a vial.
![](http://archives.lincolndailynews.com/2022/Aug/19/images/ads/current/LPL_small%201.gif)
Bavarian Nordic has raised doubts about the safety of the method, citing
a lack of data and evidence that injecting Jynneos in this way could
result in increased reactions compared to injecting it underneath the
skin.
The additional doses would be available for states and local health
departments that administer the vaccine intradermally, and have used 90%
of their current supply, White House monkeypox response coordinator Bob
Fenton said.
The U.S. is also making 50,000 courses of SIGA Technologies Inc's TPOXX
antiviral treatment available for people who test positive, said Fenton.
State and local health departments can start ordering them next week.
[to top of second column]
|
![](../images/081922PIX/health13.jpg)
Workers sit outside of D.C. Health's first monkeypox vaccination
clinic, which is administering the first Jynneos vaccine doses
distributed in the U.S. capital, in Washington, U.S., June 28, 2022.
REUTERS/Gavino Garay
![](http://archives.lincolndailynews.com/2019/Sep/05/images/ads/current/stclara_lda_SPONSOR_090519.png)
In addition, President Joe Biden's administration is setting aside
vaccine doses for areas hosting large gatherings of high-risk groups, he
said, which state and local health departments can order on top of their
existing allocations and supply.
"HHS is launching a pilot program that will provide up to 50,000 doses
from the National Stockpile to be made available for pride and other
events that will have high attendance of gay and bisexual men," Fenton
added.
Around 98% of monkeypox cases nationwide occurred among those assigned
the male sex at birth, Walensky said.
Among cases with known recent sexual history and gender, 93% were among
men who reported recent sexual contact with other men, down from 99% in
late July.
The pattern of sexual transmission in men is not typical. In Africa,
where monkeypox has been circulating since the 1970s, 60% of cases are
in men, and 40% occur in women.
Of the more than 6,000 U.S. cases for which race and ethnicity data is
available, about 35% occurred among white, non-Hispanic people, Walensky
said, adding that another 28% were in Black people and 33% in Hispanic
people.
The median age of cases is 35, she added.
(Reporting by Ahmed Aboulenein and Kanishka Singh; Editing by Mark
Porter, Frances Kerry and Alexander Smith)
[© 2022 Thomson Reuters. All rights
reserved.] This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |